share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H

AbbVie | 4: Statement of changes in beneficial ownership of securities-Director WADDELL FREDERICK H

艾伯维公司 | 4：持股变动声明-董事 WADDELL FREDERICK H
美股sec公告 ·  05/07 18:31
Moomoo AI 已提取核心信息
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
On May 3, 2024, Frederick H. Waddell, associated with AbbVie Inc. [ABBV], was granted 1,322 shares of common stock at no cost. Following this transaction, Waddell's direct holdings in the company increased to a total of 27,755 shares. The grant, which is part of the company's compensation or incentive program, reflects AbbVie's ongoing commitment to align the interests of its executives with those of its shareholders. The transaction was completed successfully, with no subsequent sales reported.
2024年5月3日，与艾伯维公司 [ABBV] 关联的弗雷德里克·瓦德尔免费获得了1,322股普通股。在这笔交易之后，瓦德尔在该公司的直接持股量增加到27,755股。该补助金是公司薪酬或激励计划的一部分，反映了艾伯维一直致力于使其高管的利益与股东的利益保持一致。交易成功完成，未报告后续销售情况。
2024年5月3日，与艾伯维公司 [ABBV] 关联的弗雷德里克·瓦德尔免费获得了1,322股普通股。在这笔交易之后，瓦德尔在该公司的直接持股量增加到27,755股。该补助金是公司薪酬或激励计划的一部分，反映了艾伯维一直致力于使其高管的利益与股东的利益保持一致。交易成功完成，未报告后续销售情况。
有用
没用

该公告为独立文件：

独立文件1

独立文件2

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息